Inherited fundus disorders are genetically determined in terms of the course of the disease as well as the prognosis, and treatments are only temporary to improve the symptoms, but not the outcome. Retinitis pigmentosa, a common form of retinitis pigmentosa, begins in adolescence and progresses to middle age with visual field defects and vision loss. During this time, medications can be used to nourish the retina, improve microcirculation, and slow down the course of the disease, but the end result is still retinal atrophy, a large portion of the field of vision loss, and a severe loss of visual acuity, which is the result of genetically predetermined hereditary fundopathy. Treatment is possible, but it can only improve the symptoms, not determine the final prognosis or cure. A cure can only be achieved with gene therapy, which is currently under research, and there are no obvious therapeutically significant gene therapy programs available.